Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.25 BATS BZX Real-Time Price As of 12:51pm ET |  -0.04 / -1.75%Today’s Change | 1.43 Today|||52-Week Range 3.50 | +16.58% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 8.3M | 22.0M | 7.2M | -- | |
| Short Term Investment Cash | -2.6M | 13.8M | -14.9M | -- | ||
| Cash & Short Term Investments | 8.3M | 22.0M | 7.2M | -- | ||
| Receivables | Receivables | 19.0K | 49.0K | 184.0K | -- | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Prepaid Expenses | 87.0K | 93.0K | 1.4M | -- | |
| Current Assets | 8.4M | 22.2M | 8.8M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 23.0K | 37.0K | 195.0K | -- | |
| Depreciation | -18.0K | -23.0K | -46.0K | -- | ||
| Other Assets | 12.0K | 52.0K | 1.6M | -- | ||
| Total Assets | 8.4M | 22.2M | 10.5M | -- | ||
| Liabilities | Accounts Payable | 445.0K | 537.0K | 603.0K | -- | |
| Short Term Debt | 17.0M | 5.3M | 0.00 | -- | ||
| Accrued Expenses | 541.0K | 1.3M | 1.5M | -- | ||
| Other Current Liabilities | 2.9M | 1.3M | 1.5M | -- | ||
| Other Liabilities | 20.4M | 7.1M | 2.7M | -- | ||
| Total Liabilities | Long Term Debt | 5.1M | 0.00 | 1.1M | -- | |
| Other Liabilities | 310.0K | 325.0K | 506.0K | -- | ||
| Total Liabilities | 25.8M | 7.5M | 4.3M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 54.7M | 99.2M | 115.7M | -- | ||
| Common Equity | -72.2M | -84.4M | -109.5M | -- | ||
| Total Shareholder Equity | -17.4M | 14.8M | 6.2M | -- | ||
| Share Information | Common Shares Outstanding | 16.1M | 16.1M | 17.8M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
